Development of rosuvastatin flexible lipid-based nanoparticles: promising nanocarriers for improving intestinal cells cytotoxicity
Abstract Background Rosuvastatin (RSV) is a poorly water-soluble drug that has an absolute oral bioavailability of only 20%. The aim of this work was to prepare a positively charged chitosan coated flexible lipid-based vesicles (chitosomes) and compare their characteristics to the corresponding nega...
Saved in:
Main Author: | Tarek A. Ahmed (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2020-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Promising prospects of lipid-based topical nanocarriers for the treatment of psoriasis
by: Meraj Alam, et al.
Published: (2023) -
Polycaprolactone Nanoparticles as Promising Candidates for Nanocarriers in Novel Nanomedicines
by: Sylwia Łukasiewicz, et al.
Published: (2021) -
PLGA and PDMS-based in situ forming implants loaded with rosuvastatin and copper-selenium nanoparticles: a promising dual-effect formulation with augmented antimicrobial and cytotoxic activity in breast cancer cells
by: Amr Maged, et al.
Published: (2024) -
Development of novel rosuvastatin nanostructured lipid carriers for oral delivery in an animal model
by: Li J, et al.
Published: (2018) -
LIPID-LOWERING EFFICACY OF ROSUVASTATIN COMPARED WITH OTHER STATINS
by: A. N. Meshkov
Published: (2015)